SOURCE: Burrill & Company

Burrill & Company

April 15, 2013 08:45 ET

Life Sciences Leaders Launch Aging Conference

Burrill & Buck Aging Meeting Will Consider the Challenge of Finding and Moving New Therapies to Market

SAN FRANCISCO, CA--(Marketwired - Apr 15, 2013) - Graying populations and the growing burden placed by diseases of aging on healthcare systems around the world are creating a new urgency for the discovery and development of new treatments and cures. The inaugural Burrill & Buck Aging Meeting will bring together leading researchers, investors, and industry executives to share insights into cutting-edge aging research, explore the need for transformational care delivery and access, and discuss the challenges of translating scientific discoveries into therapies.

Burrill & Company, a global financial services firm focused exclusively on the life sciences, and the Buck Institute for Research on Aging, the nation's first independent research facility focused solely on understanding the connection between aging and chronic disease, are organizing the meeting.

The meeting, taking place May 20-21 in Novato, California at the Buck Institute for Research on Aging, will feature keynotes by former Kaiser Permanente CEO David Lawrence, Buck Institute professor Judith Campisi, and author David Duncan Ewing. A full agenda can be found on the website

"Aging is the single greatest force that is weighing on healthcare systems," says G. Steven Burrill, CEO of Burrill & Company. "It is essential that we not only understand the science of aging and the role it plays in driving chronic disease and disability, but consider how we can expedite the development of needed new therapies, advance new regenerative medicines, and reform healthcare to match the needs of a changing population."

"Aging is the largest single risk factor for most chronic diseases," says Brian Kennedy, PhD, Buck Institute President and CEO. "By slowing aging we would be able to prevent or delay a myriad of conditions, such as Alzheimer's, heart disease, cancer and osteoporosis, among others. Given the aging of the population and the crisis in healthcare it's essential that we focus our efforts on the area where we stand to gain the most benefit -- aging." 

The worldwide population aged 65 years and older is expected to triple by 2050 to 1.5 billion people. Though developed nations have the oldest average populations today, developing nations have the greatest growth rates of older people. With that growth will be a corresponding increase in diseases of aging, such as cancer, diabetes, cardiovascular disease, and neurodegenerative diseases, across the globe.

In an effort to encourage participants to improve their own health and wellness, all attendees to the event will be given a complimentary Fitbit One, a digital health device that monitors calories, activity, and sleep. Because seating for this event is limited, interested parties are encouraged to register early.

About Burrill & Company
Founded in 1994, Burrill & Company is a diversified global financial services firm focused on the life sciences industry. With $1.5 billion in assets under management, the firm's businesses include venture capital/private equity, merchant banking, and media. By leveraging the scientific and business networks of its team, Burrill & Company has established unrivaled access and visibility in the life sciences industry. This unique combination of resources and capabilities enables the company to provide life sciences companies with capital, transactional support, management expertise, insight, market intelligence, and analysis through its investments, conferences, and publications. Headquartered in San Francisco, the company oversees a global network of offices throughout the United States, Latin America, Europe, and Asia. For more information visit:

About Buck Institute for Research on Aging
The Buck Institute is the U.S.'s first and foremost independent research organization devoted to Geroscience -- the study of the connection of normal aging and chronic disease. Based in Novato, California, the Buck is dedicated to extending "healthspan," the healthy years of human life, and does so utilizing a unique interdisciplinary approach involving laboratories studying the mechanisms of aging and those focused on specific diseases. Buck scientists strive to discover new ways of detecting, preventing and treating age-related conditions such as Alzheimer's and Parkinson's diseases, cancer, cardiovascular disease, macular degeneration, osteoporosis, diabetes and stroke. In their collaborative research, they are supported by the most recent developments in genomics, proteomics, stem cell technology, and bioinformatics. For more information:

Contact Information

  • Contacts:
    For Burrill & Company:
    Daniel Levine
    Managing Director
    Burrill & Company
    Email Contact

    For The Buck Institute:
    Kris Rebillot
    Director of Communications
    The Buck Institute for Research on Aging
    Email Contact